Adults with asthma and depression or anxiety face significantly higher risk of asthma attacks, new UK study finds.
For the 25 million Americans living with asthma, the fear of experiencing an attack without quick access to medication is all too real. While rescue inhalers remain the gold standard for treating ...
Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...
Wheezing is a whistling sound caused by narrowed airways and is common in asthma. Asthma involves airway inflammation leading ...
Recent research highlights the risk posed to cannabis workers by ground cannabis dust, which led to a $3 million payout in Missouri.
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...
Asthmatics know they should avoid substances which trigger attacks, but have you ever heard about avoiding words or rooms? New research from the University of Wisconsin-Madison suggests that such ...
News-Medical.Net on MSN
Monthly biologic injection improves severe asthma control and reduces steroid use
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with ...
WAYFINDER trial of tezepelumab monthly injection shows oral steroid reduction for most severe asthma
The international WAYFINDER trial – led by King’s College London – has shown that for severe asthma patients the use of ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...
A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.
CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results